Serum chemerin in children with excess body weight may be associated with ongoing metabolic complications - A pilot study

Serum level of chemerin may serve as a measure of ongoing obesity-related inflammation, early marker of subclinical liver dysfunction and metabolic syndrome in overweight pediatric patients.